Lexicon Pharmaceuticals, Inc. (LXRX): Long-Term Debt
Older than the company's other figures. The latest Long-Term Debt is for the year ended 2022-12-31, while the company's latest annual report covers the year ended 2025-12-31. Its later filings do not report this line under the concept TickerFacts maps.
$48.60M
As of 2022-12-31
-42.0%
3-year compound annual growth
-28.0%
5-year compound annual growth
+7.6%
10-year compound annual growth
| Period ended | Long-Term Debt | Change YoY | Source filing |
|---|---|---|---|
| 2022-12-31 | $48.60M | n/a | 2023-03-03, Balance as of period end |
| No annual figure between 2019-12-31 and 2022-12-31. | |||
| 2019-12-31 | $248.63M | -0.5% | 2020-03-12, Balance as of period end |
| 2018-12-31 | $249.91M | -0.7% | 2019-03-15, Balance as of period end |
| 2017-12-31 | $251.59M | +148.0% | 2018-03-01, Balance as of period end |
| 2016-12-31 | $101.45M | -4.1% | 2017-03-06, Balance as of period end |
| 2015-12-31 | $105.81M | -1.7% | 2016-03-11, Balance as of period end |
| 2014-12-31 | $107.67M | +392.1% | 2015-03-12, Balance as of period end |
| 2013-12-31 | $21.88M | -6.7% | 2014-03-07, Balance as of period end |
| 2012-12-31 | $23.45M | n/a | 2013-03-11, Balance as of period end |